We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Rinvoq
Australian Public Assessment Report
Device/Product Name
Rinvoq
Active ingredients
Upadacitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-00116-1-3
Submission Type
Extension of indication
Decision
Approved